The key to unlocking faster and more efficient clinical trials
Clinical trials are a crucial part of the drug development process, yet more than half (55%) of global trials are terminated due to not being able to recruit sufficient participants and four in five (80%) are forced to add new sites to a study after failing to enrol sufficient participants.